Long-term effects of neuroleptic drugs on the neuroendocrine system.
Meltzer
H Y
HY
D000568:Amenorrhea / Q000139:chemically induced; D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001927:Brain Diseases / Q000139:chemically induced*; D001943:Breast Neoplasms / Q000139:chemically induced; D004361:Drug Tolerance; D004700:Endocrine System Diseases / Q000139:chemically induced*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D005687:Galactorrhea / Q000139:chemically induced; D006177:Gynecomastia / Q000139:chemically induced; D006801:Humans; D008032:Limbic System; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D010900:Pituitary Diseases / Q000139:chemically induced; D011247:Pregnancy; D011388:Prolactin / Q000378:metabolism; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy; D012735:Sexual Dysfunction, Physiological / Q000139:chemically induced
D014150:Antipsychotic Agents; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone